Elisa Donato
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers.
Journal: Translational oncology
Published: October 16, 2025
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML.
Journal: Cell stem cell
Published: October 09, 2025
Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.
Journal: Cancer research
Published: September 12, 2024
A noncanonical enzymatic function of PIWIL4 maintains genomic integrity and leukemic growth in AML.
Journal: Blood
Published: October 11, 2022
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.
Journal: Cancer discovery
Published: August 23, 2022
HAPLN1 potentiates peritoneal metastasis in pancreatic cancer.
Journal: Nature communications
Published: June 14, 2022
Targeting the Leukemic stem cell protein machinery by inhibition of mitochondrial pyrimidine synthesis.
Journal: EMBO molecular medicine
Published: June 13, 2022
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer.
Journal: Cell reports
Published: January 19, 2022
Decoding YAP dependent transcription in the liver.
Journal: Nucleic acids research
Published: January 05, 2022
Last Updated: 09/26/2026